To ALL! Urgent!
In response to your message and subsequent communications I contacted the webmaster of "www.omigene.com", Robert Gibson. Because of legal considerations he removed the following lines from the website (but still confirms their accuracy):
"In a subsequent phone conversation regarding the matter, Mr. Mahler indicated: Further, OmniGene Diagnostics, Inc. has been in default of its license agreement since May of 1995, for use of the patent(s) promoted as its proprietary claim on the periodontal market."
Furthermore, he provided details on Mr. Scacci that expose OMGD as a rather troublesome investment. The claims are so severe, that I decided to sell immediately (even with the 4to1 split pending) and to inform the SEC. By the way, doesn't that answer an earlier question about this rather unusual way of anouncing a split.
The open questions concern: a) several 100,000 of tradable shares of stock issued under Regulation D Rule 504 for zero $$ (To whom and for what? To friends and family members?...) b) Mr. Scacci's affiliation with brokers that allegedly operated under varying identities c) the financial transactions on Mr. Scacci's Groupo Uno, Inc. account and their possible relationship to the trade of OMGD stocks, d)......
Shall I continue? I think you got the picture.
I also want to remind everyone, that QMGD has only licensed the patent on their possible (but questionable) gene-testing cash-cow from Omnigene, Inc., they don't own it. If they indeed fail to fulfill their licence agreement, OMGD has nothing......sorry, that's not very accurate, I should say: investors have nothing, OMGD has at least their money.
Draw your own conclusions. I simply hope that everyone gets, what everyone deserves. Let's see what the SEC says.
Peter
PS: I wonder if OMGD's "board" contains some familiar names...... |
